Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)
China · Delayed Price · Currency is CNY 23.27
+0.11 (0.47%)
Apr 28, 2026, 3:04 PM CST
SHE:000766 Revenue
Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd had revenue of 300.10M CNY in the quarter ending March 31, 2026, with 0.27% growth. This brings the company's revenue in the last twelve months to 1.17B, down -11.72% year-over-year. In the year 2025, Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd had annual revenue of 1.17B, down -11.54%.
Revenue (ttm)
1.17B
Revenue Growth
-11.72%
P/S Ratio
19.12
Revenue / Employee
791.07K
Employees
1,480
Market Cap
22.38B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.17B | -152.60M | -11.54% |
| Dec 31, 2024 | 1.32B | -150.79M | -10.23% |
| Dec 31, 2023 | 1.47B | 2.60M | 0.18% |
| Jan 1, 2023 | 1.47B | -44.73M | -2.95% |
| Jan 1, 2022 | 1.52B | 403.68M | 36.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Apeloa Pharmaceutical Co.,Ltd | 9.50B |
| Zhejiang Huahai Pharmaceutical | 8.71B |
| Tasly Pharmaceutical Group | 8.35B |
| Jiangsu Nhwa Pharmaceutical Co., LTD | 6.01B |
| Hubei Jumpcan Pharmaceutical | 5.90B |
| Kangmei Pharmaceutical | 5.25B |
| Chengdu Kanghong Pharmaceutical Group | 4.43B |
| Betta Pharmaceuticals | 3.73B |